Judd Moul MD

PubMed

• Genomic Prostate Score (GPS) as a Prognostic Biomarker in Patients With Localized Prostate Cancer Undergoing Focal Therapy.
  Sriram Deivasigamani, Srinath Kotamarti, Mahdi Mottaghi, Eric S Adams, Alireza Ghoreifi
  The Prostate. 2026-06-01
• 1 citations
  Real-world analyses of major adverse cardiovascular events and mortality risk after androgen deprivation therapy initiation in black vs. white prostate cancer patients.
  Judd W Moul, Deborah M Boldt-Houle, Mack Roach 3rd
  Prostate Cancer and Prostatic Diseases. 2025-12-01
• Comparative Economic Evaluation of Radical Prostatectomy, Radiation, and Ablative Techniques in the Management of Localized Prostate Cancer.
  Mahdi Mottaghi, Alireza Ghoreifi, Sriram Deivasigamani, Eric S Adams, Sudharshanan Balaji
  Cancers. 2025-08-28

Journal Articles

• Race is associated with discontinuation of active surveillance of low-risk prostate cancer: Results from the Duke Prostate Center.  
  Abern MR, Bassett MR, Tsivian M, Bañez LL, Polascik TJ, Ferrandino MN, Robertson CN, Freedland SJ, Moul JW, Prostate Cancer Prostatic Dis, 1/1/2013
• African-American men with low-grade prostate cancer have higher tumor burdens: Results from the Duke Prostate Center.  
  Tsivian M, Bañez LL, Keto CJ, Abern MR, Qi P, Gerber L, Moul JW, Polascik TJ, Prostate Cancer Prostatic Dis, 1/1/2013
• Preoperative predictors of pathologic stage T2a and pathologic Gleason score < 6 in men with clinical low-risk prostate cancer treated with radical prostatectomy: R...  
  Fu Q, Moul JW, Banez L, Sun L, Mouraviev V, Xie D, Polascik TJ, Med Oncol, 1/1/2013

Books/Book Chapters

• Comprehensive Textbook of Genitourinary Oncology 
  Banez LL, Freedland SJ, Moul JW. Recurrence Following Radical Prostatectomy: Definitions and ManagementEditors: PT Scardino, MJ Zelefsky, WM Linehan, J Sheinfeld, NJ Vogelzang.Lippincott, Williams & Wilkins, New York, NY.2011
• Conn's Current Therapy 2011. 
  Chapter: Benign Prostatic Hyperplasia. 
  Moul JWEditors: Bope ET, Kellerman RD, Rakel RE.Elsevier, Inc., Burlington, MA.2011
• The 5-Minute Urology Consult, Second Edition. 
  Editors: Gomella LG, Andriole GL, Burnett AL, Casale AJ, Flanigan RC, Keane TE, Moul JW, Thomas R.Lippincott Williams & Wilkins/Wolters Kluwer, Philadelphia, PA.2010

Abstracts/Posters

• Investigator-initiated pilot study of sunitinib malate in patients with newly diagnosed prostate cancer prior to prostatectomy: A trial of the DoD/PCF Prostate Cancer ...
  George DJ, Halabi S, Zurita AJ, Creel P, Mundy K, Turnbull JD, Yenser Wood SE, Armstrong AJ, Varley RJ, Madden J, Moul JW, J Clin Oncol, 1/1/2011
• Switching from leuprolide to degarelix vs continuous degarelix treatment-Effects on long-term prostate-specific antigen control.
  Crawford ED, Moul JW, Shore ND, Olesen TK, Persson B, J Urol, 1/1/2010
• External validation of the SEARCH model for predicting aggressive recurrence after prostatectomy: Results from the Duke Prostate Center database.
  Teeter A, Sun L, Moul J, Freedland S, J Urol, 1/1/2010

Lectures

• 7th Community Oncology Conference 
  Global Academy for Medical Education (Elsevier), Las Vegas, Nevada - 3/30/2012
• Nerve-Sparing Radical Prostatectomy: Open vs. Laparoscopic vs. Robotic: How I do it: Control of Santorini's Plexus, Dissection of Seminal Vesicles. 
  4th World Congress on Controversies in Urology, Paris, France. - 1/27/2011
• The Case for Surgery for High Risk Disease. 
  Genitourinary Cancers Symposium, San Francisco, CA. - 3/5/2010

Other

• Individualizing Therapy for the Prostate Cancer Patient: A Growing Set of Options. 
  Moul JW
  Webcast: Virtual Prostate Summit, Duke University, Durham, NC. - 4/17/2012
• Male Stress Incontinence 
  Moul JW
  National Association for Continence, Charleston, SC. - 1/1/2009
• What's New in Prostate Cancer Management: A View from the Duke Prostate Center 
  Moul JW
  The Wake County Physician magazine. - 1/1/2009